ASCO 2015 | Clinical developments in the treatment for melanoma

Name: Clinical developments in the treatment for melanoma
Uploaded: 2015-05-30T00:00:00.000Z
Duration: 5 min
Description: Axel Hauschild, MD, of University of Schleswig-Holstein, Kiel, Germany, reviews the clinical trial data for new treatments in melanoma presented at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting. He highlights trials on combined BRAF and MEK inhibition versus BRAF inhibition alone, and immunotherapy drug combinations.

Axel Hauschild • 30 May 2015

ASCO 2015

Skin Cancer Ipilimumab Nivolumab Pembrolizumab

Axel Hauschild, MD, of University of Schleswig-Holstein, Kiel, Germany, reviews the clinical trial data for new treatments in melanoma presented at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting. He highlights trials on combined BRAF and MEK inhibition versus BRAF inhibition alone, and immunotherapy drug combinations.